EXAM 4 —

EXAM 4 — COMPLETE STUDY NOTES



1. RENAL/GU PATHOPHYSIOLOGY — 5 QUESTIONS

Kidney functions

The kidneys have several major jobs:

1. Blood pressure control

The kidneys help regulate blood pressure through control of:

  • Fluid volume

  • Electrolytes

  • Renal mechanisms involved in BP regulation

2. Erythropoietin production

The kidneys produce erythropoietin, which regulates red blood cell production.

Therefore:

Kidney disease → decreased erythropoietin → decreased RBC production → anemia → pallor/fatigue

3. Filtration and waste removal

The kidneys:

  • Filter waste products from the blood

  • Excrete them as urine

When kidney function decreases:

waste products accumulate.

4. Acid-base regulation

The kidneys help maintain normal acid-base balance.

5. Electrolyte regulation

They regulate electrolytes such as:

  • Sodium

  • Potassium

  • Calcium

  • Phosphate

6. Water/fluid balance

The kidneys determine how much water is retained versus excreted.

Kidney dysfunction can therefore cause:

fluid retention → edema → weight gain

7. Vitamin D activation

The kidneys synthesize vitamin D into its active form.

This is important for calcium/phosphate balance and bone health. Week 8- Renal and GU(4)




RENAL DISEASE RISK FACTORS

Your lecture identifies:

  • Diabetes mellitus

  • Hypertension

  • Increasing age

  • Family history

  • Glomerulonephritis

  • Medication use

    • NSAIDs

    • Antibiotics

  • Obesity

  • Polycystic kidney disease

  • Pyelonephritis

  • Smoking

  • Urinary obstruction

    • Tumors

    • Enlarged prostate

    • Stones




POLYCYSTIC KIDNEY DISEASE

PKD = fluid-filled cysts develop in the kidneys.

The cysts can interfere with normal kidney function.

Possible manifestations/complications:

  • Pain

  • Infection

  • Hypertension

  • Progressive renal failure




PYELONEPHRITIS

Pyelonephritis = kidney infection.

The lecture says it is usually caused by E. coli ascending from the bladder.

A urinary catheter increases risk.

If untreated:

kidney infection → chronic kidney damage




GLOMERULOPATHIES

Glomerular disease can impair filtration.

Expected findings:

  • Proteinuria

  • ↓ GFR

  • Edema

  • Hypertension

It can progress to:

ESRD/end-stage renal disease.




NEPHROTIC SYNDROME

Important concept:

Massive protein loss

→ decreased protein in blood
→ fluid moves into tissues
→ edema

Associated with:

  • Massive protein loss

  • Edema

  • Hypertension

  • Progression toward ESRD




RENAL CALCULI

Renal calculi = kidney stones.

The lecture says they are often calcium-based.

Risk factors

  • Hypertension

  • High-protein intake

  • High-sodium intake

  • Immobility

  • Family history

  • Hyperparathyroidism

Major manifestation

Severe flank pain/renal colic

Prevention

The lecture emphasizes:

  • 2–3 L fluid/day

  • Limit sodium

  • Limit protein

  • Avoid excessive calcium supplements




AKI — ACUTE KIDNEY INJURY

AKI = sudden reduction in kidney function.

It results from an insult to the nephron.

The lecture describes:

  • Altered laboratory values

  • Decreased urine output

There are three categories.




PRE-RENAL AKI

The problem occurs before the kidney:

decreased blood flow/perfusion to the kidneys

Examples:

  • Burns

  • Hemorrhage

  • Hypovolemic shock

  • Prolonged vomiting

  • Prolonged diarrhea

Think:

Not enough blood getting to the kidneys.




INTRA-RENAL AKI

The kidney tissue itself is damaged.

Examples:

  • Nephrotoxic medications

  • Aminoglycosides

  • Contrast media

  • Prolonged ischemia

Think:

Actual kidney tissue injury.




POST-RENAL AKI

The problem occurs after the kidney:

urine outflow is blocked.

Examples:

  • BPH

  • Blood clots

  • Renal stones

  • Tumors

Think:

Urine can't get out.




CKD — CHRONIC KIDNEY DISEASE

CKD is:

Progressive and irreversible loss of kidney function over months to years.

As functioning nephrons are lost:

↓ GFR

Therefore the kidneys become less able to:

  • Remove waste

  • Regulate electrolytes

  • Maintain acid-base balance

  • Control fluid volume

  • Control BP

What happens to remaining nephrons?

Remaining nephrons initially compensate through:

hyperfiltration

This temporarily helps maintain GFR.

But eventually:

hyperfiltration → additional nephron damage → further kidney-function loss.

Two major consequences to remember

↓ erythropoietin

→ anemia

↓ vitamin D activation

→ calcium/phosphorus imbalance

→ bone demineralization

→ renal osteodystrophy

The lecture also describes inflammatory-cell infiltration, activation/loss of renal cells, extracellular-matrix production, and fibrosis/scarring as part of progressive CKD damage.




2. RENAL/GU CLINICAL SIGNS — 5 QUESTIONS

The blueprint specifically wants:

  • Fluid imbalance

  • Edema

  • Weight changes

  • BP variations

  • Altered mental status

  • Urinary incontinence 2302 Exam 4 Blueprint -1




DAILY WEIGHTS

The most sensitive indicator of fluid balance.

Important number:

1 kg = 2.2 lb ≈ 1 liter of fluid

Daily weight is considered more reliable than I&O alone.

Example

If a patient gains:

2.2 lb overnight

that corresponds approximately to:

1 L of fluid gain.




SKIN/MUCOUS MEMBRANES IN RENAL DISEASE

Assess for:

Edema

Fluid accumulation in tissues.

Uremic frost

Rare, severe finding.

Pruritus

Itching.

Pallor

Related to:

↓ erythropoietin → anemia

Dry skin / poor turgor

Can indicate altered fluid status.




NEUROLOGICAL FINDINGS

Uremia can affect the brain.

Look for:

  • Confusion

  • Lethargy

  • Difficulty concentrating

  • Asterixis

Asterixis

An advanced neurological finding associated with uremia.




URINARY INCONTINENCE

There are several types.




URGE INCONTINENCE

The patient suddenly feels a strong urge to urinate and may not make it to the bathroom.

Associated with:

overactive detrusor muscle.

Possible associated conditions:

  • Urinary infection

  • BPH obstruction

  • Parkinson disease

  • MS

  • Stroke




STRESS INCONTINENCE

Urine leaks when intra-abdominal pressure increases.

Examples:

  • Coughing

  • Sneezing

  • Bending

Related to loss of pelvic muscle support.

Risk factors listed in lecture include:

  • Estrogen depletion

  • Obesity

  • Childbirth trauma

  • Cancer therapy

  • Spinal nerve damage from diabetes




MIXED INCONTINENCE

Combination of:

urge + stress




OVERFLOW INCONTINENCE

The bladder doesn't empty completely.

→ residual urine

→ urinary stasis

→ increased infection risk.

Common in:

older adult males with BPH.




FUNCTIONAL INCONTINENCE

The urinary system itself is intact.

The problem is something else prevents the person from reaching/responding to the toilet in time.

Example:

Immobility.




URINARY TERMINOLOGY

Anuria

<50 mL urine/24 hours

Dysuria

Painful or difficult urination.

Oliguria

Reduced urine output.

May indicate:

  • Dehydration

  • Fluid retention

  • Decreasing kidney function

Urinary frequency

Urination multiple times during the day/night.

Urgency

A compelling need to urinate.

Nocturia

Nighttime urination.

Polyuria

>2.5 L/24 hours




3. FOCUSED RENAL/GU ASSESSMENT — 2 QUESTIONS

BLADDER ASSESSMENT

Palpate the:

suprapubic area

to assess for:

bladder distention.

Empty bladder

Not normally palpable.

Mildly full bladder

  • Slightly firm

  • Nontender

  • Below umbilicus

Full bladder

  • Firm

  • May extend above umbilicus




CVA TENDERNESS

Assess the:

costovertebral angle (CVA).

Pain/tenderness can indicate:

kidney involvement.

Adult kidneys

Normally:

not palpable.




URINE ASSESSMENT

Assess:

Color

  • Pale yellow

  • Dark

  • Amber

  • Red

  • Cloudy

Clarity

  • Clear

  • Cloudy

Odor

  • Strong

  • Foul

  • Sweet

Amount

Normal adult output:

≥30 mL/hr

Also assess for:

  • Sediment

  • Mucus

  • Blood




I&O

Monitor:

  • Intake

  • Output

  • Intake vs output

  • Trends over time

Pay particular attention to:

  • Oliguria

  • Anuria

  • Postoperative patients

  • CHF patients




4. RENAL/GU MEDICATIONS — 5 QUESTIONS

OXYBUTYNIN — DITROPAN

Class

Anticholinergic.

What does it do?

Normally acetylcholine binds to M3 receptors in the bladder and causes the detrusor muscle to contract.

Oxybutynin:

blocks M3 receptors

→ decreases detrusor contractions
→ increases bladder capacity
→ decreases urgency
→ decreases frequency
→ decreases urge incontinence.

Used for

Overactive bladder / urinary incontinence.

Adverse effects

Because it blocks acetylcholine, think:

“everything dries up.”

The lecture specifically lists:

  • Mydriasis/dilated pupils

  • Drowsiness

  • Confusion

  • Anticholinergic effects

Nursing considerations

Monitor:

  • Anticholinergic effects

  • I&O

  • Bladder distention

Because it can increase intraocular pressure:

eye examinations are important.

Safety

Do not give with:

  • Glaucoma

  • GU obstruction

  • GI obstruction

Week 8- Renal and GU(4)




BETHANECHOL — URECHOLINE

Class

Cholinergic.

Opposite of oxybutynin

Bethanechol:

stimulates acetylcholine

→ stimulates muscarinic receptors

→ bladder contracts

→ sphincter relaxes

→ promotes urination.

Used for

Urinary retention

Specifically:

  • Acute postoperative nonobstructive retention

  • Postpartum nonobstructive retention

  • Neurogenic bladder with retention

Adverse effects

Cholinergic effects:

  • Increased salivation

  • Increased gastric acid secretion

  • Vasodilation

  • Hypotension

  • Fainting

  • Bronchospasm

  • Diarrhea

Nursing

Monitor:

  • Vital signs

  • Respiratory status

  • Postural hypotension

Report:

  • Shortness of breath

  • Bronchospasm

The patient may urinate frequently.

Lecture teaching:

Increase fluid intake to compensate.

Major interaction

Do not give with cholinesterase inhibitors.

Why?

Both increase acetylcholine.

→ excessive cholinergic effect. Week 8- Renal and GU(4)




PHENAZOPYRIDINE

Class

Urinary analgesic.

Action

Provides local analgesic action on the urinary tract mucosa.

Used for

Relief of:

  • Urinary pain

  • Burning

  • Frequency

  • Urgency

  • Irritation of urinary tract mucosa

EXPECTED EFFECT

Urine may become:

reddish-orange.

Saliva and tears can also become reddish-orange.

This is an expected medication effect.

Before giving

Assess:

  • Renal function

  • Liver function

because toxicity can occur in patients with renal/hepatic insufficiency.

Patient should NOT:

  • Take extra doses

  • Wear contact lenses

  • Drink alcohol

  • Take it longer than 2 days

Why not longer than 2 days?

It could mask symptoms of a bacterial infection that isn't resolving.

Week 8- Renal and GU(4)




DIURETICS

Used for:

  • Fluid overload

  • BP control

Common in:

CHF + renal overlap

Important kidney consideration

Diuretics can cause/worsen:

pre-renal AKI if overused

because excessive fluid removal can decrease renal perfusion.




ACE INHIBITORS / ARBs

Examples:

  • Lisinopril

  • Losartan

Purpose

Can protect the kidneys in:

  • Diabetes

  • Hypertension

Important effects

Decrease intraglomerular pressure.

Watch for

  • Increased creatinine initially

  • Hyperkalemia




HYPERKALEMIA MEDICATIONS

Lecture lists:

Sodium bicarbonate

Used in hyperkalemia management.

Calcium gluconate

Used in hyperkalemia management.

Insulin + dextrose

Used in hyperkalemia management.

Sodium polystyrene

Used to help manage elevated potassium.

Critical concept

Hyperkalemia can be life-threatening.




CALCIUM CARBONATE

Purpose

Used as a phosphate binder.

Helps prevent:

hyperphosphatemia

and associated bone disease.

Key administration point

Take with meals.




WEEK 9 — ENDOCRINE

15 questions




1. ENDOCRINE PATHOPHYSIOLOGY — 5 QUESTIONS

The blueprint specifically requires:

  • Thyroid

  • Parathyroid

  • Pituitary

  • Adrenal

  • Hormone regulation/feedback

  • Hyperthyroidism

  • Hypothyroidism

  • Hyperparathyroidism

  • Hypoparathyroidism

  • DI

  • SIADH

  • Addison's

  • Cushing's 2302 Exam 4 Blueprint -1




THYROID HORMONES

T4 — THYROXINE

Contains:

4 iodine atoms

It is the:

more abundant thyroid hormone.




T3 — TRIIODOTHYRONINE

Contains:

3 iodine atoms

It is:

more active.




TSH

Produced by:

anterior pituitary

TSH stimulates the thyroid to:

  • Produce thyroid hormones

  • Release T3/T4

  • Increase metabolic activity




CALCITONIN

Produced by:

parafollicular/C cells of thyroid

Released when:

calcium is high.

Effects:

  • Inhibits osteoclasts

  • Increases calcium excretion

  • Lowers serum calcium




IODINE DEFICIENCY

Iodine is needed for T3/T4 production.

↓ iodine

→ ↓ T3/T4

→ ↑ TSH

→ thyroid stimulation/enlargement

→ goiter

The lecture identifies iodine deficiency as the most common worldwide cause of goiter.




HYPERTHYROIDISM

Problem

Overproduction of T3/T4

Most common cause

Graves disease

Why symptoms happen

Thyroid hormone increases metabolic activity.

Therefore expect:

  • Weight loss

  • Heat intolerance

  • Sweating

  • Tachycardia

  • Diarrhea

  • Fine tremors

  • Mood changes

  • Weakness




GRAVES DISEASE

Autoimmune disorder.

Antibodies such as:

TRAb/TSI

stimulate thyroid follicular cells.

→ excessive T3/T4 production

→ goiter

Can also cause:

exophthalmos.

Complications

  • Arrhythmias

  • Heart failure

  • Miscarriage

  • Preterm birth

  • Preeclampsia

  • Osteoporosis

  • Thyroid storm




THYROID STORM

A life-threatening extreme increase in thyroid hormone activity.

Potential triggers include:

  • Infection

  • Trauma

  • Abrupt discontinuation of antithyroid medication

  • Acute illness

  • Stroke

  • Childbirth

  • Inadequately treated hyperthyroidism

  • After thyroid removal

Findings

  • Severe tachycardia

  • Fever

  • Dehydration

  • Heart failure

  • Confusion/delirium

  • Nausea/vomiting

  • Diarrhea

  • Agitation/anxiety

  • Shakiness

  • Jaundice

  • Loss of consciousness

Can progress to:

  • Clots

  • Heart failure

  • Seizures

  • Delirium

  • Coma




HYPOTHYROIDISM

Problem

Inadequate T3/T4

Most common cause

Hashimoto thyroiditis

Findings

Think of metabolism slowing down:

  • Bradycardia

  • Cold intolerance

  • Constipation

  • Fatigue

  • Weight gain

  • Goiter




HASHIMOTO THYROIDITIS

Autoimmune destruction of thyroid tissue.

Antibodies/T-cell activity:

→ destruction of thyroid follicular cells

→ fibrosis

→ decreased thyroid hormone secretion.




MYXEDEMA COMA

Severe complication of untreated hypothyroidism.

Can cause:

  • Hypothermia

  • Cardiovascular collapse

  • Hypoventilation

  • Hyponatremia

  • Hypoglycemia

  • Lactic acidosis

  • Coma




PARATHYROID

There are:

4 parathyroid glands

near the thyroid.

They produce:

PTH — parathyroid hormone

PTH works with:

  • Vitamin D3

  • Calcitonin

to regulate calcium.

PTH targets:

  • Kidneys

  • Skeleton

  • Intestines




HYPOPARATHYROIDISM

Problem

Insufficient PTH

→ dangerously low calcium

Because calcium and phosphate have an inverse relationship:

↓ calcium → ↑ phosphate

Causes

  • Autoimmune disease

  • Idiopathic disease

  • Thyroid/parathyroid surgery

Findings

  • Tetany

  • Paresthesia

  • Prolonged QT

  • Chvostek sign

  • Trousseau sign

Treatment can include:

  • IV calcium gluconate

  • Oral calcium

  • Vitamin D supplements Week 9 PPT




CHVOSTEK SIGN

Tap the facial nerve.

Positive:

involuntary twitching of facial muscles.

Indicates:

nerve hyperexcitability associated with hypocalcemia.




TROUSSEAU SIGN

Inflate BP cuff above systolic pressure for approximately:

3 minutes

Positive:

hand spasm/carpopedal spasm.

Also indicates:

hypocalcemia/neuromuscular excitability.




PITUITARY

Known as the:

“master gland.”

Anterior pituitary

Produces hormones involved in:

  • Growth/development

  • Metabolism

  • Reproduction

  • Stress

Posterior pituitary

Stores/releases:

  • Oxytocin

  • ADH/vasopressin




ADH

ADH regulates:

water balance.

It causes the kidneys to:

reabsorb water.

Therefore:

More ADH → more water retained

Less ADH → more water lost in urine




DIABETES INSIPIDUS

Problem

Chronic underproduction of ADH OR mutation in the ADH receptor.

→ kidneys cannot retain water.

→ large amounts of water lost in urine.

Major findings

  • Polyuria >3 L/24 hr

  • Polydipsia

  • Dehydration

  • Hypernatremia

  • Fatigue

  • Hypotension

  • Tachycardia

  • Dizziness

  • Weakness

  • Possible loss of consciousness

  • Hypovolemic shock

Labs

  • ↓ urine osmolality

  • ↑ serum osmolality

  • Serum sodium assessed

Treatment

  • Treat underlying cause

  • Maintain fluid intake

  • Desmopressin

  • Vasopressin Week 9 PPT




SIADH

Problem

Too much/unsuppressed ADH

→ kidneys retain excessive water

→ hypervolemia

→ dilutional hyponatremia

Causes listed

  • Certain cancers

  • CNS disturbances

  • Certain medications

  • Pulmonary disease

  • Vascular disease

  • MI

  • Sometimes hereditary

Early findings

  • Malaise

  • Nausea

  • Vomiting

As sodium falls:

  • Lethargy

  • Headache

  • Obtundation

  • Seizures

  • Coma

  • Respiratory arrest

Critical sodium

<120 mEq/L → coma/respiratory arrest

Labs

  • ↓ serum osmolality

  • ↓ serum sodium

  • ↑ urine sodium

Treatment

  • Treat underlying cause

  • Fluid restriction

  • Sodium chloride

  • Loop diuretics such as furosemide

  • Hypertonic saline for severe symptoms

  • Demeclocycline

  • Tolvaptan

The lecture emphasizes careful sodium monitoring because correcting sodium too rapidly can cause permanent brain injury. Week 9 PPT




ADRENAL GLANDS — ADDISON'S

Addison's disease

Autoimmune adrenal insufficiency.

Antibodies attack adrenal tissue.

→ decreased cortisol and aldosterone production.

Findings

  • Fatigue

  • Weight loss

  • Weakness

  • Abdominal pain

  • Nausea/vomiting

  • Dizziness

  • Hyperpigmentation




ADRENAL CRISIS

Also called:

Addisonian crisis

Rapid onset and emergency.

Can be triggered by:

  • Abrupt steroid discontinuation

  • Inadequate steroid dosing

  • Infection

  • Trauma

Findings

  • Nausea

  • Vomiting

  • Abdominal pain

  • Hypotension

  • Altered mental status

  • Obtundation

  • Shock

Initial treatment

  • IV fluids

  • Dextrose

  • Hydrocortisone

Lecture gives approximately:

25% mortality. Week 9 PPT




CUSHING'S SYNDROME

Problem

Excess cortisol exposure over a long period.

Effects

Excess cortisol:

→ ↑ gluconeogenesis

→ insulin resistance

→ altered metabolism of glycogen/fats

→ impaired protein synthesis

→ poor wound healing

→ osteoporosis

→ poor immune function.

Most common cause

Long-term/high-dose glucocorticoid use

Cushing disease

A pituitary tumor/adenoma:

→ ↑ ACTH

→ adrenal glands produce ↑ cortisol.

Diagnostics

  • Dexamethasone suppression test

  • 24-hour urine free cortisol

  • Serum electrolytes

  • Fasting blood glucose

Possible labs:

  • Hypokalemia

  • Hypocalcemia

  • Elevated fasting glucose

Treatment

Depends on cause.

May include:

  • Gradual steroid taper for exogenous Cushing's

  • Mifepristone

  • Adrenal surgery

  • Hypophysectomy

  • Radiation

  • Bilateral adrenalectomy

  • Bisphosphonates

  • Potassium

  • Diuretics

  • Antihypertensives




2. ENDOCRINE ASSESSMENT — 5 QUESTIONS

Hyperthyroidism

Expect:

  • Weight loss

  • Heat intolerance

  • Sweating

  • Tachycardia

  • Tremors

  • Diarrhea

  • Mood changes

  • Weakness

Hypothyroidism

Expect:

  • Weight gain

  • Bradycardia

  • Cold intolerance

  • Constipation

  • Fatigue

  • Goiter

Hypoparathyroidism

Think:

LOW calcium

Look for:

  • Tetany

  • Paresthesia

  • Prolonged QT

  • Chvostek

  • Trousseau

DI

Think:

LOW ADH → LOTS OF WATER LOST

  • Polyuria

  • Polydipsia

  • Dehydration

  • Hypernatremia

  • Hypotension

  • Tachycardia

SIADH

Think:

HIGH ADH → TOO MUCH WATER RETAINED

  • Fluid excess

  • Hyponatremia

  • ↓ serum osmolality

  • ↑ urine sodium

  • Neurological changes

Addison's

  • Weight loss

  • Weakness

  • Fatigue

  • Hypotension/dizziness

  • Hyperpigmentation

  • N/V

  • Abdominal pain

Cushing's

  • Excess cortisol

  • Hyperglycemia

  • Hypokalemia

  • Hypocalcemia

  • Poor wound healing

  • Osteoporosis

  • Poor immunity

  • Fluid-volume concerns




3. ENDOCRINE MEDICATIONS — 5 QUESTIONS

METHIMAZOLE

Action

Inhibits thyroid hormone synthesis

→ decreases thyroid hormone levels

→ decreases hyperthyroid manifestations.

Indication

Hyperthyroidism

Adverse effects

  • Agranulocytosis

  • Thrombocytopenia

  • Aplastic anemia

  • Fever

  • Hypoglycemia

  • Jaundice

  • Urticaria

  • Epigastric distress

  • Arthralgia

Nursing

Monitor:

  • CBC

  • Coagulation studies

  • Liver function

  • Thyroid levels

Patient teaching

Take as prescribed.

Monitor weight weekly.

Report:

  • Sore throat

  • Skin eruptions

  • Fever

  • Headache

  • Malaise

The lecture says to report weight gain of:

3 lb/24 hr or 5 lb/week

Precautions/interactions

  • Liver dysfunction

  • Anticoagulants

  • Beta blockers

  • Digitalis

  • Theophylline

Lecture also says:

Avoid dietary iodine and avoid pregnancy. Week 9 PPT




LEVOTHYROXINE

Action

Thyroid hormone replacement.

Replaces deficient thyroid hormone.

Indication

  • Hypothyroidism

  • TSH suppression in specified pituitary conditions

Adverse effects

  • Irregular heartbeat

  • Heat intolerance

  • Irregular breathing

  • Irritability

  • Nausea/vomiting

  • Tremors

  • Decreased urine output

Nursing

Monitor:

thyroid levels

Therapy is generally:

lifelong

Administration

Take:

in the morning on an empty stomach

At least:

30 minutes before food/caffeine

Separate from:

  • Calcium

  • Iron

by at least:

4 hours

Contraindication

Untreated adrenal insufficiency




CALCIUM CARBONATE

Action

Acts in the small intestine and helps increase circulating ionized calcium while reducing serum phosphate.

Indications

  • Hypocalcemia

  • Phosphate reduction/binding

  • Antacid use

Adverse effects

  • Upset stomach

  • Vomiting

  • Abdominal pain

  • Bloating

  • Constipation

  • Dry mouth

  • Loss of appetite

  • Metallic taste

  • Increased urination

  • Kidney stones

Hypercalcemia can produce:

  • Fatigue

  • Confusion

  • Constipation

  • Increased thirst

  • Frequent urination

Nursing

Monitor:

  • Calcium

  • Vitamin D

  • Phosphate

  • PTH

  • Thyroid hormones

Teaching

Eat foods high in:

  • Calcium

  • Vitamin D

Take exactly as prescribed.

Interactions

Calcium can interfere with absorption of:

  • Tetracyclines

  • Bisphosphonates

  • Thyroid hormone replacements

These should be separated in administration time.

Contraindications/precautions

  • Hypersensitivity

  • Hypercalcemia

  • Kidney stones

  • Malabsorption disorders Week 9 PPT




CALCITRIOL

What it is

An activated vitamin D preparation.

Vitamin D promotes:

  • Calcium absorption

  • Phosphorus absorption

  • Maintenance of calcium/phosphate levels

Indications

The lecture identifies calcitriol for:

  • Hypocalcemia

  • Hypoparathyroidism

Adverse effects

  • Constipation

  • Dry mouth

  • Bone pain

  • Metallic taste

  • Polyuria

  • Pruritus

  • Increased AST

  • Increased BUN

Contraindications

  • Hypercalcemia

  • Vitamin D toxicity

  • Hypersensitivity

  • Malabsorption disorders

Vitamin D toxicity may produce:

  • Recurrent vomiting

  • Confusion

  • Apathy

  • Dehydration




CINACALCET

Class

Calcimimetic.

Action

Amplifies the:

calcium-sensing receptor (CaSR)

→ suppresses PTH

→ decreases blood calcium.

Indications

  • Primary hyperparathyroidism

  • Secondary hyperparathyroidism

  • Hypercalcemia

Adverse effects

  • Nausea/vomiting

  • Abdominal pain

  • Muscle cramps

  • Bone pain

  • Increased fracture risk

Nursing

Monitor:

  • Calcium

  • Vitamin D

  • Phosphate

  • PTH

  • Thyroid hormones

Administration

Take:

with meals

Tablet should not be:

  • Chewed

  • Crushed

  • Divided

Caution

Use cautiously with:

  • Severe liver impairment

  • Upper GI bleeding

  • Hypotension

  • Heart failure

  • Bone disease




ALENDRONATE

Class

Bisphosphonate.

Action

Attaches to bone/hydroxyapatite binding sites.

When osteoclasts attempt to resorb bone:

→ alendronate interferes with osteoclast activity

→ ↓ bone resorption

→ ↑ bone density.

Indication

Prevention and treatment of osteoporosis

Adverse effects

  • GI discomfort

  • Nausea

  • Esophageal irritation

  • Musculoskeletal pain

  • Bone pain

  • Osteonecrosis of jaw

  • Atypical fractures

VERY IMPORTANT ADMINISTRATION

Take with water.

Remain:

upright for at least 30–60 minutes

This reduces esophageal irritation.

Contraindications

  • Esophageal disorders

  • Unable to remain upright

  • Hypocalcemia

  • Hypersensitivity




VASOPRESSIN

What is it?

ADH.

Action

Binds vasopressin receptors in the kidney.

→ increases water reabsorption

→ decreases water lost in urine

→ helps prevent dehydration.

It also causes:

vasoconstriction

→ increases BP.

Uses in lecture

  • Shock

  • Cardiac arrest

  • ADH-related disorders

Adverse effects

Lecture table lists:

  • Bradycardia

  • Increased bilirubin

  • Hyponatremia

  • Ischemic lesions

  • Decreased platelets

Nursing

Monitor:

  • I&O

  • Sodium

  • Other electrolytes

  • Urine specific gravity

  • Fluid excess

Watch for:

water intoxication/fluid excess

including:

  • Nausea/vomiting

  • Headache

  • Mental-status changes

  • Muscle cramps

  • Drowsiness

Also watch for fluid loss:

  • Extreme thirst

  • Dry mouth

  • Fatigue

Teaching

  • Journal symptoms

  • Monitor I&O

  • Report concerning symptoms

  • Do not stop unless directed




DEMECLOCYCLINE

Action

Interferes with vasopressin

→ regulates water balance

→ increases urine output

→ decreases excess water.

Indication

SIADH

Adverse effects

  • Nausea

  • Vomiting

  • Diarrhea

  • Photosensitivity

Nursing

Monitor:

  • I&O

  • Electrolytes

  • Sodium

  • Urine specific gravity

Watch for fluid overload.

Teaching

Report:

sudden weight gain

because this can indicate fluid overload.

Contraindication

Hypersensitivity. Week 9 PPT




METHYLPREDNISOLONE

Class

Glucocorticoid.

Action

Binds glucocorticoid receptors.

→ decreases inflammatory molecules

→ inhibits immune response

→ decreases inflammation.

Effects

  • Anti-inflammatory

  • Immunosuppressive

Adverse effects

  • Weight gain

  • Hypertension

  • Osteoporosis

  • Increased infection risk

  • Skin atrophy

  • Hyperglycemia/glycosuria

Nursing

Monitor:

  • Vital signs

  • Sodium

  • Potassium

  • BUN

  • Creatinine

  • Glucose

  • Aldosterone

  • Cortisol

  • Bone density

Assess for:

fluid-volume excess

Teaching

  • Take as prescribed

  • Avoid people who are sick

  • Report infection

  • Report edema

  • Report weight gain >2 lb in 3 days or 5 lb/week

  • Limit salt

  • Do NOT stop abruptly

Contraindications/precautions

  • Hypersensitivity

  • Systemic active fungal infections




FLUDROCORTISONE

Class

Mineralocorticoid.

Action

Binds mineralocorticoid receptors in kidneys.

→ increases sodium reabsorption

→ increases potassium excretion

→ regulates fluid/electrolyte balance.

Indication

Primary/secondary adrenal insufficiency in:

Addison's disease

Adverse effects

  • Edema

  • Cardiac enlargement

  • Potassium loss

  • Muscle weakness

  • Abdominal distention

  • Impaired wound healing

  • Growth suppression

  • Hyperglycemia

  • Urticaria

  • Hypertension/hypokalemia

Nursing

Monitor:

  • Vital signs

  • Sodium

  • Potassium

  • BUN

  • Creatinine

  • Glucose

  • Aldosterone

  • Cortisol

  • Bone density

Assess for:

fluid-volume excess

Teaching

  • Avoid sick people

  • Report edema

  • Report weight gain >2 lb/3 days or 5 lb/week

  • Limit salt

  • Report infection

  • Do not stop abruptly

Contraindications/precautions

  • Systemic fungal infection

  • Hypersensitivity

  • May mask infection Week 9 PPT




WEEK 10 — DIABETES

16 questions




1. RISK FACTORS + PATHOPHYSIOLOGY — 3 QUESTIONS

INSULIN

Insulin is produced by:

β cells of the pancreatic islets of Langerhans.

After eating:

Carbohydrates → glucose → blood glucose rises

→ pancreas releases insulin

→ insulin allows:

  • Muscle cells

  • Fat cells

  • Liver cells

to absorb glucose.

Result

Blood glucose decreases.

Insulin also participates in:

  • Lipid metabolism

  • Protein metabolism

  • Anti-inflammatory effects 2302 week 10 Diabetes




GLUCAGON

Produced by:

α cells of pancreas.

When blood glucose is low:

glucagon stimulates:

glycogen breakdown in the liver

→ glucose enters bloodstream

→ blood glucose increases.




TYPE 1 DIABETES

Autoimmune destruction of:

β cells

→ pancreas stops producing insulin.

Without insulin:

glucose can't enter cells normally

→ blood glucose rises.

Patients require:

lifelong insulin.

Risk factors

  • Young age

  • Family history

  • Certain viral infections

Clinical manifestations

  • Weight loss

  • High blood glucose

  • Acute onset

  • Polydipsia

  • Polyphagia

  • Polyuria




TYPE 2 DIABETES

The body:

  • Doesn't produce enough insulin

  • Or doesn't use insulin effectively

→ insulin resistance

β cells retain some insulin-producing ability.

Risk factors

  • Prediabetes

  • Obesity

  • Age ≥45

  • Family history

  • Sedentary lifestyle

  • Fatty liver

  • History of gestational diabetes

Clinical manifestations

Symptoms develop more slowly.

  • Fatigue

  • Frequent infections

  • High blood glucose




GESTATIONAL DIABETES

Pregnancy increases insulin demands.

β cells cannot adequately compensate.

→ reduced insulin sensitivity

→ hyperglycemia.

The lecture says it affects up to:

14% of pregnancies.

Usually returns to normal after pregnancy, but increases future risk of:

Type 2 diabetes. 2302 week 10 Diabetes




2. HYPOGLYCEMIA VS HYPERGLYCEMIA — 2 QUESTIONS

HYPERGLYCEMIA

Lecture defines:

>110 mg/dL

Why it happens

Too little insulin or too much insulin resistance.

Findings

  • Polyuria

  • Polydipsia

  • Polyphagia

  • Blurred vision

  • Restlessness

  • Unintentional weight loss

  • Abdominal pain

  • Vomiting

  • Drowsiness

  • Hot/dry skin

  • Hypotension

  • Coma

Severe hyperglycemia can lead to:

DKA → coma → death

2302 week 10 Diabetes




HYPOGLYCEMIA

Think:

The brain/body isn't getting enough glucose.

Findings:

  • Tremors/shakiness

  • Nervousness/anxiety

  • Sweating

  • Chills

  • Clamminess

  • Irritability

  • Mood swings

  • Confusion

  • Tachycardia

  • Dizziness

  • Lightheadedness

  • Hunger

  • Nausea

  • Pallor

  • Sleepiness

  • Weakness

  • Fatigue

  • Blurred/impaired vision

  • Tingling/numbness of lips/tongue/cheeks

  • Headache

  • Coordination problems

  • Irregular heart rate

2302 week 10 Diabetes




3. NURSING ASSESSMENT — 2 QUESTIONS

General survey

Assess:

  • Appearance

  • Body habitus

  • Level of consciousness

  • Orientation

Look for:

  • Fatigue

  • Weight changes

  • Confusion

  • Diaphoresis




Vital signs

Assess:

  • BP

  • HR

  • RR

  • Temperature

  • O₂ saturation

Look for:

  • Hypertension

  • Tachycardia

  • Fever

  • Kussmaul respirations




BLOOD GLUCOSE

Assess:

  • Capillary glucose

  • Trends

  • Timing

Determine whether the patient is experiencing:

hypoglycemia or hyperglycemia.




METABOLIC ASSESSMENT

Assess:

  • A1C

  • Ketones

  • Symptoms




RESPIRATORY ASSESSMENT

Assess:

  • Rate

  • Depth

  • Effort

Important finding

Deep, rapid breathing → possible DKA

This is:

Kussmaul respirations.




SUBJECTIVE ASSESSMENT

Ask about:

  • Obesity history

  • Diabetes history

  • Unplanned weight loss

  • Neuropathic pain

  • Polyuria

  • Polydipsia




PHYSICAL FINDINGS

Possible:

  • Decreased touch sensation

  • Decreased temperature sensation

  • Blurred vision

  • Hypertension

  • Kussmaul respirations

  • Loss of ankle deep-tendon reflexes

  • Weak dorsalis pedis pulses

  • Weak posterior tibial pulses

  • Dry skin

  • Muscle atrophy

  • Foot ulceration

  • Obesity

  • Candida infection

  • Thick hyperpigmentation under skin folds

  • Poor skin turgor




MEDICATION ASSESSMENT

Assess:

  • Insulin/oral medications

  • Dose

  • Timing

  • Adherence

Look for:

  • Missed doses

  • Frequent hypoglycemia




INSULIN INJECTION ASSESSMENT

Assess:

  • Site rotation

  • Storage

  • Administration technique

Look for:

Lipohypertrophy

and poor injection technique.




NUTRITION

Assess:

  • Meal timing

  • Carbohydrate intake

  • Appetite

Look for:

  • Inconsistent meals

  • Poor intake




GI

Assess:

  • Nausea

  • Vomiting

  • Abdominal pain

Important:

Vomiting → possible DKA




RENAL/GU

Assess:

  • Urine output

  • Frequency

  • Nocturia

Look for:

  • Polyuria

  • Dehydration

  • UTI




FLUID STATUS

Assess:

  • I&O

  • Edema

Look for:

  • Dehydration

  • Dependent edema




4. DIABETES COMPLICATIONS — 2 QUESTIONS

MICROVASCULAR

Retinopathy

→ vision damage

→ blindness

Neuropathy

→ nerve damage

→ pain/numbness/tingling

Nephropathy

→ kidney damage

→ possible ESRD.




MACROVASCULAR

Diabetes damages blood vessels and increases risk of:

  • Cardiovascular disease

  • MI

  • Stroke

  • Peripheral vascular disease




OTHER COMPLICATIONS

  • ESRD

  • Amputation

  • Hypoglycemia

  • Gastroparesis

  • Increased infection/sepsis risk

  • Foot ulcers




DKA

Usually associated with:

Type 1 diabetes

Development

Can occur:

within 24 hours

Triggers

  • Infection

  • Sepsis

  • Stress

  • Missed insulin

Pathophysiology

Not enough insulin

→ body can't use glucose normally

→ begins breaking down lipids

→ lipids produce:

ketones

→ ketoacidosis.




HHS

Usually associated with:

Type 2 diabetes

Development

Days to weeks

Common trigger

  • Illness

  • Infection

Pathophysiology

Severe/chronic hyperglycemia

→ severe dehydration

→ weakness

→ confusion

Lecture gives mortality as:

up to 20%.




5. DIABETES MEDICATIONS — 3 QUESTIONS

INSULIN

Therapeutic effect

Decreases blood glucose.

Insulin promotes:

glucose uptake by cells.

Major adverse effect

HYPOGLYCEMIA

Other adverse effects listed:

  • Weakness

  • Headache

  • Nausea

  • Diarrhea

  • Abdominal pain

  • Cough

  • Weight gain

  • Edema

  • Injection-site irritation/reaction

  • Lipodystrophy

Major nursing point

Hypoglycemia risk increases when insulin reaches:

peak time

because peak = maximum glucose-lowering effect.




INSULIN SAFETY

The lecture specifically calls for:

independent double checks.

Double-check:

  • Client identifiers

  • Insulin type

  • Product

  • Dose

  • Measured dose

Especially important when the patient receives:

more than one type of insulin.

Administration

Use:

insulin syringes

for insulin administration. 2302 week 10 Diabetes




RAPID-ACTING INSULIN

Examples:

  • Aspart — Novolog

  • Glulisine — Apidra

  • Lispro — Humalog

Onset

15–30 minutes

Peak

1–2 hours

Duration

2–4 hours

Meal timing

Take:

15 minutes before meal OR immediately after meal

Often combined with longer-acting insulin.




SHORT-ACTING INSULIN

Example:

Regular insulin

  • Humulin R

  • Novolin R

Onset

30 min–1 hr

Peak

2–3 hr

Duration

3–6 hr

Meal timing

30–60 minutes before meal




INTERMEDIATE-ACTING INSULIN

Example:

NPH/isophane

  • Humulin N

  • Novolin N

Onset

2–4 hours

Peak

4–12 hours

Duration

12–18 hours

Often provides coverage:

12 hours or longer/overnight.




LONG-ACTING INSULIN

Examples:

  • Degludec — Tresiba

  • Detemir — Levemir

  • Glargine — Lantus

Onset

1–2 hours

Peak

Does not peak

Duration

Up to 24 hours

Provides coverage for approximately the entire day.




INSULIN APPEARANCE

Most insulin:

clear

Exception:

NPH = cloudy

2302 week 10 Diabetes




GLIPIZIDE

Class

Sulfonylurea

Administration

Time with meals

Peak

1–3 hours

Major adverse effect

Hypoglycemia

Important interaction

Hypoglycemia can be potentiated by:

  • NSAIDs

  • Other highly protein-bound drugs




METFORMIN

Class

Biguanide

Major nursing concern

Lactic acidosis

Contraindications

  • Renal disease

  • Hepatic disease

Contrast studies

Temporarily discontinue for radiologic studies involving:

intravascular iodinated contrast.

Stop immediately if

Signs of lactic acidosis occur or the patient develops a condition associated with:

  • Hypoxemia

  • Dehydration

  • Sepsis

Common adverse effects

  • Diarrhea

  • Nausea/vomiting

  • Weakness

  • Flatulence

  • Indigestion

  • Abdominal discomfort

  • Headache




SITAGLIPTIN

Class

DPP-IV inhibitor

Administration

Can be taken:

with or without food.

Adverse effects/concerns

  • Hypoglycemia

  • Hypersensitivity reactions

  • Blisters/erosions

  • Headache

  • Pancreatitis symptoms

  • Heart failure

  • Severe arthralgia

  • Upper-respiratory infection

2302 week 10 Diabetes




GLUCAGON

Class

Hypoglycemia treatment.

Action

Increases blood glucose by:

stimulating glycogen breakdown in the liver.

Peak

15 minutes

Forms

  • Injectable

  • Nasal spray

When used

When the patient is:

  • Semiconscious

  • Unconscious

  • Unable to ingest sugar-containing food

Nursing

After administration:

Reassess blood glucose in 15 minutes.

Adverse effects

  • Nausea

  • Vomiting

  • Temporary tachycardia

Contraindications

  • Hypersensitivity

  • Pheochromocytoma